StockData
Mesoblast Ltd logo

Mesoblast Ltd (MESO) stock

MESONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30Also trades as MEOBF
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Aug 27, 2026Score 6/30
$11.91−0.54 (-4.34%)

Close on Nov 17, 2026Market cap $1.54BP/E –Yield –

Mesoblast total assets

Total assets on the balance sheet at the end of each period.

Mesoblast's total assets was $773.08M at Jun 30, 2026. For fiscal 2026 it was $773.08M, down 1.5% from the year before. The highest annual figure on record is $784.68M in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2026Jun 30, 2026$773.08M-1.5%
FY2025Jun 30, 2025$784.68M+17.3%
FY2024Jun 30, 2024$669.15M-0.0%
FY2023Jun 30, 2023$669.42M+1.1%
FY2022Jun 30, 2022$662.14M-11.1%
FY2021Jun 30, 2021$744.72M+1.5%
FY2020Jun 30, 2020$733.60M+12.5%
FY2019Jun 30, 2019$652.12M-5.8%
FY2018Jun 30, 2018$692.44M+5.6%
FY2017Jun 30, 2017$655.69M–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026$773.08M+15.5%
Q2 FY2026CQ4 2025Dec 31, 2025$782.31M+16.7%
Q4 FY2025CQ2 2025Jun 30, 2025$784.68M+17.2%
Q2 FY2025CQ4 2024Dec 31, 2024$653.32M+0.4%
Q4 FY2024CQ2 2024Jun 30, 2024$669.15M+0.2%
Q2 FY2024CQ4 2023Dec 31, 2023$670.29M-2.1%
Q4 FY2023CQ2 2023Jun 30, 2023$669.42M+1.1%
Q3 FY2023CQ1 2023Mar 31, 2023$650.44M-4.6%
Q2 FY2023CQ4 2022Dec 31, 2022$668.06M-5.2%
Q1 FY2023CQ3 2022Sep 30, 2022$684.50M-5.2%
Q4 FY2022CQ2 2022Jun 30, 2022$662.14M-11.1%
Q3 FY2022CQ1 2022Mar 31, 2022$681.69M-11.0%
Q2 FY2022CQ4 2021Dec 31, 2021$704.44M+2.5%
Q1 FY2022CQ3 2021Sep 30, 2021$721.82M+1.3%
Q4 FY2021CQ2 2021Jun 30, 2021$744.72M+1.5%
Q3 FY2021CQ1 2021Mar 31, 2021$766.13M+15.1%
Q2 FY2021CQ4 2020Dec 31, 2020$687.31M-0.4%
Q1 FY2021CQ3 2020Sep 30, 2020$712.57M+9.0%
Q4 FY2020CQ2 2020Jun 30, 2020$733.60M+12.5%
Q3 FY2020CQ1 2020Mar 31, 2020$665.79M-1.5%
Q2 FY2020CQ4 2019Dec 31, 2019$690.24M+0.3%
Q1 FY2020CQ3 2019Sep 30, 2019$653.79M-5.6%
Q4 FY2019CQ2 2019Jun 30, 2019$652.12M-0.5%
Q3 FY2019CQ1 2019Mar 31, 2019$675.71M–
Q2 FY2019CQ4 2018Dec 31, 2018$688.33M–
Q4 FY2018CQ2 2018Jun 30, 2018$692.44M–
Q4 FY2017CQ2 2017Jun 30, 2017$655.69M–

More Mesoblast figures

See a number that looks wrong?